Source: ERS Webinar 2020: COVID-19: Q and A



Rating:

Share or cite this content

Citations should be made in the following way:
Prof. Tobias Welte (Hannover , Germany), Prof. Eva Polverino (Barcelona, Spain), Prof. Chen Wang (Beijing, China), Prof. Bin Cao (Beijing, China). COVID-19: Q and A. ERS Webinar 2020: COVID-19: Q and A

Member's Comments

Fatima Alhamed Alduihi - 05.05.2020 23:24
5

Khalid Hassan Ba-Msahell - 08.04.2020 08:47
As there is a small percentage of blood sample shad positive PCR test results , suggesting that infection sometimes may be systemic. Transmission of the virus by respiratory and extrarespiratory routes may help explain the rapid spread of the disease.
So, the Question is what is the precaution should be taken by the national blood bank stoor and the precaution for blood products transfusion should be taken in these pandemic situation?
Thanks alot

Khalid Hassan Ba-Msahell - 03.04.2020 07:13
Thanks

Related content which might interest you: SARS-CoV-2 (COVID-19): Research response Source: Webinar 2020: SARS-CoV-2 (COVID-19): research response Year: 2020 Diagnosis and treatment of COVID-19 Source: Webinar 2020: Diagnosis and treatment of COVID-19 Year: 2020 Coronavirus disease: outbreak in China and globally Source: Webinar 2020 Year: 2020 Health Policy of COVID-19 management Source: ERS Webinar 2020: Health Policy of COVID-19 management Year: 2020 ERS/ATS joint webinar: Rehabilitation after COVID 19 disease Source: ERS webinar 2020: ERS/ATS joint webinar: Rehabilitation after COVID 19 disease Year: 2020 ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme Year: 2020 ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment Year: 2020 Perspectives of the management of COVID-19 infection in China Source: Webinar 2020: Perspectives of the management of COVID-19 infection in China Year: 2020 The influenza pandemic: 1918 compared to 2005 Source: Annual Congress 2005 - New developments in infectious disease Year: 2005 A nosocomial outbreak of influenza during a period without influenza epidemic activity Source: Eur Respir J 2003; 21: 303-307 Year: 2003 Avian influenza and SARS – how much of a threat is it to humans and what can be done to prevent this? Source: Annual Congress 2005 - Major viral threats to the lung Year: 2005 Interview on Coronavirus COVID-19 management experience in China Source: Webinar 2020: Interview on Coronavirus COVID-19 management experience in China Year: 2020 Pathomorphology of pandemic influenza (H1N1) in terms of the present epidemic in Ukraine Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 LATE-BREAKING ABSTRACT: The analysis of a local outbreak of avian-origin influenza A (H7N9) in Shanghai Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Pandemic scenario 1: outbreak investigation Source: ERS Course 2017 - Acute respiratory pandemics: how to plan for and manage Year: 2017 Update on respiratory virus research and clinical care including influenza outbreak 2017-18, SARS, MERS and other respiratory pathogens Source: International Congress 2018 – PG3 How to plan for and manage a respiratory epidemic/pandemic Year: 2018 Influenza type A outbreak associated with myositis Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005 Can procalcitonin (PCT) be an indicator of viral severe community-acquired pneumonia (CAP) based on epidemics of influenza H1N1 in season 2015-2016? Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 The worldwide outbreak of SARS - how it spread and was controlled Source: Annual Congress 2003 - The Severe Acute Respiratory Syndrome (SARS) Year: 2003 Regional features of pneumonia caused by influenza during epidemics of influenza virus A (H1N1) in western Ukraine Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010